These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1685860)

  • 1. Raised IMP-dehydrogenase activity in the erythrocytes of a case of purine nucleoside phosphorylase (PNP) deficiency.
    Morgan G; Strobel S; Montero C; Duley JA; Davies PM; Simmonds HA
    Adv Exp Med Biol; 1991; 309B():297-300. PubMed ID: 1685860
    [No Abstract]   [Full Text] [Related]  

  • 2. Liquid-chromatographic study of purine metabolism abnormalities in purine nucleoside phosphorylase deficiency.
    Chantin C; Bonin B; Boulieu R; Bory C
    Clin Chem; 1996 Feb; 42(2):326-8. PubMed ID: 8595732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial deficiency of purine nucleoside phosphorylase: studies of purine and pyrimidine metabolism.
    Edwards NL; Gelfand EW; Biggar D; Fox IH
    J Lab Clin Med; 1978 May; 91(5):736-49. PubMed ID: 417142
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythrocyte GTP depletion in PNP deficiency presenting with haemolytic anaemia and hypouricaemia.
    Simmonds HA; Fairbanks LD; Morris GS; Timms P; Singh B; Bold A
    Adv Exp Med Biol; 1986; 195 Pt A():481-6. PubMed ID: 3088921
    [No Abstract]   [Full Text] [Related]  

  • 5. Purine nucleoside phosphorylase (PNP) deficiency: a therapeutic challenge.
    Watson AR; Simmonds HA; Webster DR; Layward L; Evans DI
    Adv Exp Med Biol; 1984; 165 Pt A():53-9. PubMed ID: 6426259
    [No Abstract]   [Full Text] [Related]  

  • 6. Partial Purine Nucleoside Phosphorylase Deficiency Helps Determine Minimal Activity Required for Immune and Neurological Development.
    Grunebaum E; Campbell N; Leon-Ponte M; Xu X; Chapdelaine H
    Front Immunol; 2020; 11():1257. PubMed ID: 32695102
    [No Abstract]   [Full Text] [Related]  

  • 7. Purine nucleoside phosphorylase deficiency.
    Markert ML
    Immunodefic Rev; 1991; 3(1):45-81. PubMed ID: 1931007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red cell metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy.
    Staal GE; Stoop JW; Zegers BJ; van der Vlist MJ; de Bruyn CH; Wadman SK
    Monogr Hum Genet; 1978; 10():104-7. PubMed ID: 102921
    [No Abstract]   [Full Text] [Related]  

  • 9. [Purine nucleoside phosphorylase (PNP) deficiency].
    Sumi S; Wada Y
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):458-9. PubMed ID: 9590100
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapy in adenosine deaminase and purine nucleoside phosphorylase deficient patients.
    Zegers BJ; Stoop JW
    Clin Biochem; 1983 Feb; 16(1):43-7. PubMed ID: 6407780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Purine nucleoside phosphorylase (PNP)].
    Sakiyama T
    Nihon Rinsho; 1996 Dec; 54(12):3220-5. PubMed ID: 8976095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of immunodeficiency caused by a purine nucleoside phosphorylase defect by using tandem mass spectrometry on dried blood spots.
    la Marca G; Canessa C; Giocaliere E; Romano F; Malvagia S; Funghini S; Moriondo M; Valleriani C; Lippi F; Ombrone D; Della Bona ML; Speckmann C; Borte S; Brodszki N; Gennery AR; Weinacht K; Celmeli F; Pagel J; de Martino M; Guerrini R; Wittkowski H; Santisteban I; Bali P; Ikinciogullari A; Hershfield M; Notarangelo LD; Resti M; Azzari C
    J Allergy Clin Immunol; 2014 Jul; 134(1):155-9. PubMed ID: 24767876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PNP (purine nucleoside phosphorylase) deficiency].
    Taniguchi A
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():372-6. PubMed ID: 12629750
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies.
    Grunebaum E; Cohen A; Roifman CM
    Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):630-8. PubMed ID: 24113229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent developmental delay despite successful bone marrow transplantation for purine nucleoside phosphorylase deficiency.
    Baguette C; Vermylen C; Brichard B; Louis J; Dahan K; Vincent MF; Cornu G
    J Pediatr Hematol Oncol; 2002 Jan; 24(1):69-71. PubMed ID: 11902746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purine nucleoside phosphorylase deficiency presenting as severe combined immune deficiency.
    Somech R; Lev A; Grisaru-Soen G; Shiran SI; Simon AJ; Grunebaum E
    Immunol Res; 2013 May; 56(1):150-4. PubMed ID: 23371835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary immunodeficiencies: development and trends].
    Stoop JW; Zegers BJ
    Ned Tijdschr Geneeskd; 1986 Sep; 130(36):1592-5. PubMed ID: 3093903
    [No Abstract]   [Full Text] [Related]  

  • 18. Adenosine deaminase and purine nucleoside phosphorylase deficiencies: evaluation of therapeutic interventions in eight patients.
    Markert ML; Hershfield MS; Schiff RI; Buckley RH
    J Clin Immunol; 1987 Sep; 7(5):389-99. PubMed ID: 3116034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purine nucleoside phosphorylase deficiency: biochemical properties and heterogeneity in two families.
    Wortmann RL; Andres C; Kaminska J; Mejias E; Gelfand E; Arnold W; Rich K; Fox IH
    Arthritis Rheum; 1979 May; 22(5):524-31. PubMed ID: 36100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the metabolism of allopurinol. Formation of allopurinol-1-riboside in purine nucleoside phosphorylase deficiency.
    Reiter S; Simmonds HA; Webster DR; Watson AR
    Biochem Pharmacol; 1983 Jul; 32(14):2167-74. PubMed ID: 6409116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.